Produktbild: Cancer Diagnostics
- 13%

Cancer Diagnostics Current and Future Trends

13% sparen

185,99 € UVP 213,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

09.12.2010

Abbildungen

XI, 508 p.

Herausgeber

Robert M. Nakamura + weitere

Verlag

Humana Press

Seitenzahl

508

Maße (L/B/H)

25,4/17,8/2,8 cm

Gewicht

967 g

Sprache

Englisch

ISBN

978-1-61737-399-2

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

09.12.2010

Abbildungen

XI, 508 p.

Herausgeber

Verlag

Humana Press

Seitenzahl

508

Maße (L/B/H)

25,4/17,8/2,8 cm

Gewicht

967 g

Sprache

Englisch

ISBN

978-1-61737-399-2

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Cancer Diagnostics
  • Part I: Introduction

    General Considerations in the Use and Application of Laboratory Tests for the Evaluation of Cancer
    Robert M. Nakamura and Wayne W. Grody

    New Insights and Future Advances in Cancer Diagnostics: Limitations of Conventional Tumor Markers
    Yasushi Kasahara and Yutaka Tsukada

    The Changing Role of the Pathologist in the Management of the Cancer Patient
    Raymond B. Nagle

    Part II: Serological Tumor Markers

    Types of Circulating Tumor Markers and Their Clinical Applications
    James T. Wu

    Identification of Risk Factors for Early Neoplasm
    James T. Wu

    Emerging Circulating Tumor Markers
    James T. Wu

    Prostate Cancer Markers: From Discovery to the Clinic
    Judith A. Finlay, Stephen D. Mikolajczyk, Thomas M. Pribyl, R. Bruce Wallace, and Harry G. Rittenhouse

    Serum Tumor Marker Test Profile in Testicular Germ-Cell Tumors
    Frank J. Liu, Robert M. Nakamura, C. Howard Tseng, and Kevin S. Liu

    Autoantibodies, Autoimmunity, and Cancers: Markers for Identification of Early Stages of Tumors
    Robert M. Nakamura and Eng M. Tan

    Part III: Cellular Tumor Markers. MHC Tetramers: A Tool for Direct Ex Vivo Detection and Enumeration of Tumor-Specific Cytotoxic T Lymphocytes
    Jennie C. C. Chang, Ferdynand Kos, Charles T. Nugent, and Kristine Kuus-Reichel

    New Applications of Flow Cytometry in Cancer Diagnosis and Therapy
    Sophie Song and Faramarz Naeim

    Molecular Diagnostics in Neoplastic Hematopathology
    Daniel A. Arber

    HER2 and Topoisomerase IIa in Breast Carcinoma
    Kenneth J. Bloom

    Study of Sentinel Lymph Nodes in the Staging of Malignant Neoplasms
    Alice A. Roberts and Alistair J. Cochran

    A Marker for Early Diagnosis of Lung Cancer: The Heterogeneous Nuclear Ribonucleoprotein A2/B1 (hnRNP A2/B1)
    Jordi Tauler, Alfredo Martínez, andJames L.Mulshine

    Part IV: Molecular and Genetic Tumor Markers

    Molecular Techniques in Cancer Diagnosis and Management
    Jeffrey S. Ross, Karen Gray, Rebecca Mosher, and James Stec

    DNA Repair Defects in Cancer
    Ramune Reliene and Robert H. Schiestl

    Chromosomal and Molecular Cytogenetic Assays for Evaluation of Human Tumors
    Peter C. Hu, Vicki L. Hopwood, and Armand B. Glassman

    Microsatellite Alterations as Diagnostic and Prognostic Markers in Patients With Cancer
    Bret Taback and Dave S. B. Hoon

    Recent Advances in Molecular Classification and Prognosis of Colorectal Cancer
    Tsung-Teh Wu and Asif Rashid

    Genetic Counseling for Hereditary Cancer Predisposition Testing
    Joyce L. Seldon and Patricia A. Ganz

    Diagnosis of Ataxia-Telangiectasia: ATM Mutations Associated With Cancer
    Midori Mitsui, Shareef A. Nahas, Helen H. Chun, and Richard A. Gatti

    Index